146 related articles for article (PubMed ID: 38190953)
1. Dendrobium huoshanense in the treatment of ulcerative colitis: Network pharmacology and experimental validation.
Yao L; Fang J; Zhao J; Yu J; Zhang X; Chen W; Han L; Peng D; Chen Y
J Ethnopharmacol; 2024 Apr; 323():117729. PubMed ID: 38190953
[TBL] [Abstract][Full Text] [Related]
2. Integrating network pharmacology and experimental verification to explore the mucosal protective effect of Chimonanthus nitens Oliv. Leaf Granule on ulcerative colitis.
Huang JQ; Cheng N; Zhong YB; Zhang ZY; Huang L; Song LZ; Li MD; Deng YF; Zhou W; Zhao HM; Liu DY
J Ethnopharmacol; 2024 Mar; 321():117540. PubMed ID: 38056534
[TBL] [Abstract][Full Text] [Related]
3. The potential mechanism of Bletilla striata in the treatment of ulcerative colitis determined through network pharmacology, molecular docking, and in vivo experimental verification.
Gong S; Lv R; Fan Y; Shi Y; Zhang M
Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):983-1000. PubMed ID: 36576506
[TBL] [Abstract][Full Text] [Related]
4. Network pharmacology dissection of multiscale mechanisms for jiaoqi powder in treating ulcerative colitis.
Wen S; Zhong Z; He L; Zhao D; Chen X; Mi H; Liu F
J Ethnopharmacol; 2021 Jul; 275():114109. PubMed ID: 33845143
[TBL] [Abstract][Full Text] [Related]
5. Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema.
Cui Y; Hu J; Li Y; Au R; Fang Y; Cheng C; Xu F; Li W; Wu Y; Zhu L; Shen H
Drug Des Devel Ther; 2023; 17():3453-3472. PubMed ID: 38024534
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Si-Wu Decoction in the treatment of ulcerative colitis revealed by network pharmacology and experimental verification.
Wang L; Liu Y; Shen G; He G; Qiu S; Li B
J Ethnopharmacol; 2023 Dec; 317():116847. PubMed ID: 37356743
[TBL] [Abstract][Full Text] [Related]
7. Integrated component identification, network pharmacology, and experimental verification revealed mechanism of Dendrobium officinale Kimura et Migo against lung cancer.
Zhao Y; Zhu S; Li Y; Niu X; Shang G; Zhou X; Yin J; Bao B; Cao Y; Cheng F; Li Z; Wang R; Yao W
J Pharm Biomed Anal; 2024 Jun; 243():116077. PubMed ID: 38460276
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.
Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W
Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
[TBL] [Abstract][Full Text] [Related]
10. Revealing the mechanism of "Huai Hua San" in the treatment of ulcerative colitis based on network pharmacology and experimental study.
Chen PY; Yuan C; Hong ZC; Zhang Y; Ke XG; Yu B; Wang C; Xiao XC; Wu HZ; Yang YF
J Ethnopharmacol; 2021 Dec; 281():114321. PubMed ID: 34118340
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Targets and Molecular Mechanisms of Thalidomide in the Treatment of Ulcerative Colitis: Network Pharmacology and Experimental Validation.
Li J; Tao Q; Xie Y; Wang P; Jin R; Huang X; Chen Y; Zeng C
Curr Pharm Des; 2023; 29(34):2721-2737. PubMed ID: 37961863
[TBL] [Abstract][Full Text] [Related]
12. Effects of
Kang YH; Zhou T; Wu SX; Li XJ; Huang XY; Xia R; Ling YH; Zhou HT; Zhang SW; Yin WY
Am J Chin Med; 2023; 51(6):1477-1499. PubMed ID: 37530508
[No Abstract] [Full Text] [Related]
13. Investigation of the material basis and mechanism of Lizhong decoction in ameliorating ulcerative colitis based on spectrum-effect relationship and network pharmacology.
Zhang Y; Li WW; Wang Y; Fan YW; Wang QY; Liu C; Jiang S; Shang EX; Duan JA
J Ethnopharmacol; 2024 Apr; 323():117666. PubMed ID: 38159822
[TBL] [Abstract][Full Text] [Related]
14. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
15. Effective materials and mechanisms study of Tibetan herbal medicine Lagotis integra W. W. Smith treating DSS-induced ulcerative colitis based on network pharmacology, molecular docking and experimental validation.
Wang X; Zhang C; Liu L; Zhong Y; Wang Y; Liu F; Zhu J; Mu Z; Zhang S; Wang X; Zhong G; Liang J; Zeng J
J Ethnopharmacol; 2023 Jan; 301():115800. PubMed ID: 36228890
[TBL] [Abstract][Full Text] [Related]
16. Lonicera rupicola Hook.f.et Thoms flavonoids ameliorated dysregulated inflammatory responses, intestinal barrier, and gut microbiome in ulcerative colitis via PI3K/AKT pathway.
Li C; Wang L; Zhao J; Wei Y; Zhai S; Tan M; Guan K; Huang Z; Chen C
Phytomedicine; 2022 Sep; 104():154284. PubMed ID: 35777121
[TBL] [Abstract][Full Text] [Related]
17. Integrated Metabonomics and Network Pharmacology to Reveal the Action Mechanism Effect of Shaoyao Decoction on Ulcerative Colitis.
Wu J; Luo Y; Shen Y; Hu Y; Zhu F; Wu J; Liu Y
Drug Des Devel Ther; 2022; 16():3739-3776. PubMed ID: 36324421
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacology.
Yang Y; Qian C; Wu R; Wang R; Ou J; Liu S
BMC Complement Med Ther; 2023 Jan; 23(1):11. PubMed ID: 36647064
[TBL] [Abstract][Full Text] [Related]
19. Network pharmacology and experimental verification reveal the mechanism of Hedysari Radix and Curcumae Rhizoma with the optimal compatibility ratio against colitis-associated colorectal cancer.
Zhang Y; Wang Y; Xin E; Zhang Z; Ma D; Liu T; Gao F; Bian T; Sun Y; Wang M; Wang Z; Yan X; Li Y
J Ethnopharmacol; 2024 Mar; 322():117555. PubMed ID: 38110130
[TBL] [Abstract][Full Text] [Related]
20. Novel applications of Yinhua Miyanling tablets in ulcerative colitis treatment based on metabolomics and network pharmacology.
Wang C; Yu H; Li Z; Wu J; Gao P; He S; Tang D; Wang Q; Liu H; Lv H; Liu J
Phytomedicine; 2024 Jun; 128():155366. PubMed ID: 38537445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]